Lower than expected mortality with dexamethasone in toxic epidermal necrolysis: 30-year experience of a Northern Mexico reference hospital
- 1 January 2020
- journal article
- letter
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (1) , E4-E5
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisJAMA Dermatology, 2017
- New Insights into the Function of the Immunoproteasome in Immune and Nonimmune CellsJournal of Immunology Research, 2015
- Uncovering Histologic Criteria With Prognostic Significance in Toxic Epidermal NecrolysisArchives of Dermatology, 2005
- Corticosteroid Therapy in an Additional 13 Cases of Stevens-Johnson Syndrome: A Total Series of 67 CasesAllergy and Asthma Proceedings, 2000